Tacrolimus Capsule
Product Images NDC 70377-014

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tacrolimus (NDC 70377-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0.5 mg Container Label (0.5 mg Container Label Bpl)

This is a description of Tacrolimus Capsules, a prescription drug. The capsules contain 0.5mg of Tacrolimus USE and are sold in a package of 100 capsules. The usual dosage information can be found in the package insert. The package is child-resistant and should be stored between 59°F to 86°F. The manufacturer is Biocon Pharma and the drug meets USP Organic Impurities Procedure 2 but FDA approved dissolution test specifications differ from USP. There is an unvarnished area of 56 x 28 mm and a space for online batch coding and serialization prints during product batch packing.*

FDA Label Image

1 mg Container Label (1 mg Container Label Bpl)

This is a medication called Tacrolimus in capsule form. Each capsule has a capacity of 1 mg, but is not filled to the maximum capacity. It is recommended to store the medication between 15°C to 30°C. The usual dosage should be checked on the package insert. This medication is child-resistant and should be kept out of reach of children. The manufacturer is Biocon Pharma Inc. The package has a space for online batch coding and serialization prints during the product batch packing.*

FDA Label Image

5 mg Container Label (5 mg Container Label Bpl)

This is a medication package of Tacrolimus Capsules, USP. Each capsule contains Tacrolimus USP, 5 mg. The packaging contains 100 capsules and is child-resistant. The package insert provides dosage information. The medication meets USP Organic Impurities Procedure 2, but FDA approved dissolution test specifications differ from USP. Manufactured for Biocon Pharma Inc, Iselin, NJ, USA by Biocon Pharma Limited, Bengaluru, India. The package has space for online batch coding and serialization prints during product batch packing. The dimensions of the package are 125mm x 56mm.*

FDA Label Image

Tacrolimus Structural Formula (Tacrolimus Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.